DSM grapples with price

Baker, John
February 2007
ICIS Chemical Business;2/19/2007, Vol. 2 Issue 54, p4
Trade Publication
The article looks at the plan of DSM amidst pricing issues in some of the more mature parts of its nutritional products portfolio. Outgoing chairman Peter Elverding said that despite the problem, the company has chosen to defend and further strengthen its market position even at the expense of margins. He stressed that the move would mean decreased earnings in 2007. DSM chief financial officer Rolf-Dieter Schwalb revealed that basic vitamin C and carotenoids are facing low-cost competition from China and other producers.


Related Articles

  • DSM shares take plunge on weak Q4. Watts, Mark // ICIS Chemical Business Americas;2/19/2007, Vol. 271 Issue 7, p12 

    The article reports on the decline in the shares of DSM by 8.3% to €35.30 on the Euronext trading in February 2007, after it announced earnings for the fourth quarter of 2006. DSM chairman Peter Elverding explains the company's decision to reinforce its market position. The firm has...

  • DSM to Spin Off Petchems, Focus on Specialties. Alperowicz, Natasha // Chemical Week;10/4/2000, Vol. 162 Issue 37, p19 

    Reports on the strategy changes at DSM planned by Peter Elverding, the firm's chief executive officer. Plans of Elverding to spinoff the petrochemicals business of DSM; Sales target of DSM by year 2005; How DSM plans to double its engineering plastics business.

  • DSM's Elverding Urges Greater Cooperation Throughout Industry. Milmo, Sean // Chemical Market Reporter;10/04/99, Vol. 256 Issue 14, p8 

    Stresses the need for cooperation among European petrochemical manufacturers to make the industry more competitive globally. Views of Peter Elverding, chairman of DSM; Integration of production facilities; Opportunities for cooperation within the three main petrochemical clusters in Europe;...

  • DSM expands Chinese resin base. Robinson, Simon // European Chemical News;10/24/2005, Vol. 83 Issue 2168, p8 

    This article reports that DSM has bought Syntech, a Chinese company that makes and sells liquid coating resins, such as alkyds, polyesters, amino resins and acrylic resins. The firm declined to disclose the financial terms of the purchase, but said it would result in increased earnings per share...

  • DSM to Boost Specialties Through Innovation. Young, Ian // Chemical Week;10/12/2005, Vol. 167 Issue 33, p10 

    This article reports that DSM has launched a five-year strategy that aims to position the company as a more innovative producer of specialty chemicals with a broader geographic spread as of October 2005. The plan, called Vision 2010, will include capital expenditure of €500 million to...

  • DSM seeking buyer for fertiliser business unit. Robinson, Simon // ICIS Chemical Business;2/13/2006, Vol. 1 Issue 6, p4 

    The article reports on the search of DSM for a buyer for its fertiliser business DSM Agro in Geleen and Ijmuiden in the Netherlands. According to chairman Peter Elverding, the business did not have the strong global position like the other chemicals businesses of DSM. It provides a background on...

  • Promising forecast from DSM. Beacham, Will // European Chemical News;5/3/2004, Vol. 80 Issue 2098, p9 

    Reports on the move of DSM in May 2004 to raise its full year 2004 profit forecast after unveiling first quarter operating income. Reaction of ING Financial Markets to the move of DSM; Information on the business acquired by DSM from Roche; Remarks from group Chairman Peter Elverding on the...

  • Resins Acquisition Completes DSM's Transformation. Young, Ian // Chemical Week;12/22/2004, Vol. 166 Issue 42, p6 

    Reports on the acquisition of NeoResins, a coating resins business of Avecia, by DSM. Background on NeoResins; Launch of the Vision 2005 transformation strategy by DSM CEO Peter Elverding; Impact of the purchase of NeoResins on the portfolio of DSM.

  • Loyalty plan is canned. Beacham, Will // ICIS Chemical Business Americas;4/2/2007, Vol. 271 Issue 13, p13 

    The article reports on the decision of the Enterprise section of the Amsterdam Court of Appeals that forced DSM to abandon its shareholder loyalty dividend program. The court said that the proposed plan violated the principle of equality. The plan would have allowed DSM shareholders for at least...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics